The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.
 
Udit Singhal
No Relationships to Disclose
 
Stephanie Daignault-Newton
Other Relationship - American Urological Association
 
Rodney Dunn
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Honoraria - Varian Medical Systems
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Varian Medical Systems
Research Funding - Janssen (Inst)
 
Linda Okoth
No Relationships to Disclose
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Anna Johnson
No Relationships to Disclose
 
Brian R Lane
No Relationships to Disclose
 
Susan Linsell
No Relationships to Disclose
 
Ghani Khurshid
No Relationships to Disclose
 
Rohit Mehra
Patents, Royalties, Other Intellectual Property - The University of Michigan has been issued a patent on the detection of ETS gene fusions in prostate cancer, on which Rohit Mehra is listed as co-inventor.
 
Elai Davicioni
Employment - Decipher Biosciences; GenomeDx; Veracyte
Leadership - Decipher Biosciences; GenomeDx; Veracyte
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx; Veracyte
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx; Veracyte
 
Thomas Maatman
No Relationships to Disclose
 
Frank Burks
No Relationships to Disclose
 
Paul Rodriguez
No Relationships to Disclose
 
Eduardo Kleer
No Relationships to Disclose
 
Richard Sarle
No Relationships to Disclose
 
David Christopher Miller
No Relationships to Disclose
 
Michael L. Cher
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - Blue Earth Diagnostics; Myovant Sciences; Myriad Genetics; Stratify Genomics; Tempus; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)